まとめ 　

　低線量放射線照射による抗酸化的抑制、酵素的修復そして免疫システム、ROSによるDNA傷害のアポトーシスによる除去などの変異抑制システムの活性化などによって、遺伝子の変異が減少していることが放射線ホルミシス−がんによる死亡率の低下およびその他のすべての原因による死亡率の低下−の生物学的な理由をなしている。放射線ホルミシスはLNT仮説が根拠としている生物物理学的な考え方とは相対するものである。

REFERENCES

1. National Council on Radiation Protection and Measurements. Principles and Application of Collective Dose in Radiation Protection. NCRP Report No. 121. Bethesda, MD: NCRP, 1995;45.
2. Jawarowski Z. Beneficial radiation. Nukleonika 40:3-12 (1995).
3. Kostyuchenko VA, Krestina L Yu. Long-term irradiation effects in the population evacuated from the East- Urals radioactive trace area. The Sci. Total Environ. 142: 119-125 (1994).
4. Kondo S. Health Effects of Low-Level Radiation. Osaka, Japan: Kinki University Press Madison, WI: Medical Physics Publishing, 1993.
5. Cohen BL. Test of the linear no-threshold theory of radiation carcinogenesis in the low dose, low dose rate region. Health Phys 68:157-174 (1995).
6. National Academy of Sciences, Committee on Biological Effects of Ionizing Radiation. Health Risks of Radon and Other Internally Deposited Alpha Emitters (BEIR IV). Washington: National Academy Press, 1988.
7. Matanoski GM. Health effects of low-level radiation in shipyard workers final report. Report No. DOE DE- AC02-79 EV10095. Washington: US Department of Energy, 1991.
8. United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and Effects of Ionizing Radiation; UNSCEAR 1994 Report to the General Assembly, with Scientific Annexes. New York, NY: United Nations, 1994; Annex B. Adaptive Responses to Radiation in Cells and Organisms: 185-272.
9. National Academy of Sciences, Committee on Biological Effects of Ionizing Radiation. Health Effects of Exposure to Low Levels of Ionizing Radiation (BEIR V). Washington: National Academy Press, 1990.
10. Miller AB, Howe GR, Sherman GJ, Lindsay JP, Yaffe MJ, Dinner PJ, Risch HA, Preston DL. Mortality from breast cancer after irradiation during fluoroscopic examination in patients being treated for tuberculosis. N Engl J Med 321:1285-1289 (1989).
11. Howe GR, McLaughlin J. Breast cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with breast cancer mortality in the atomic bomb survivors study. Radiat Res 149: 694-707 (1996).
12. Taylor LS. Some non-scientific influences on radiation protection standards and practice. Health Phys 39: 851-874 (1980).
13. Beckman KD, Ames BN. The free radical theory of aging matures. Physiol. Rev. 78:547-581 (1998).
14. Pollycove M. Moleclar biology, epidemiology, and the demise of the linear no-threshold (LNT) hypothesis. In Proceeding of the International Symposium, International Centre for Low Dose Radiation Research. Ottawa, Canada; 1999:83-110.
15. Pollycove M, Feinenden LE. Quantification of human DNA alterations. In Proceedings of the DOE/NIH Workshop on Cellular Responses to Low Doses of Ionizing Radiation, April 1999, Washington, D.C. In press; 2000.
16. Friedberg EC, Walker GC, Siede W. DNA Repair and Mutagenesis. ASM Press, Washington, D.C., 1995.
17. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD Eds. Molecular Biology of the Cell, 3rd Ed. Garland Pub., New York, New York, 1994.
18. Ward JF. Radiation chemical methods of cell death. In Fielden EM. Fowler JF, Hendry JH, Scott D, eds, Proceedings of the 8th International Congress of Radiation Research, Vol. II. London, England; Taylor & Francis; 1987;162-168.
19. Pollycove M, Feinendegen LE. Low-level radiation improvement of health and therapy of cancer. In Proceedings of the 10th International Congress of the International Radiation Protection Association. Hiroshima, Japan, May 2000, Hiroshima, Japan, In press; 2000.
20. Sohal RS, Weindruch R. Oxidative stress, caloric restriction, and aging. Science 273:59-63 (1996).
21. Feinendegen LE, Loken MK, Booz J., Muhlensiepen H., Sondhaus CA, Bond VP, Cellular mechanisms of protection and repair induced by radiation exposure and their consequences for cell system responses. Stem Cells (Suppl. 1): 7-20 (1995).
22. Feinendegen LE, Sondhaus CA, Bond VP, Muhlensiepen H. Radiation effects induced by low doses in complex tissue and their relation to cellular adaptive responses. Mutation Res. 199-205 (1996).
23. Varmus H, Weinberg RA. Genes and the Biology of Cancer. New York, NY: Scientific American Library;1993:153.
24. Ames BN, Gold LS, Willet WC. The causes and prevention of cancer. Proc Natl Acad Sci USA 92:5258- 5265 (1995).
25. Yamaoka K. Increased SOD activities and decreased lipid peroxide in rat organs induced by low X- irradiation. Free Radical Biol Med 11:3-7 (1991).
26. Le XC, Xing JZ, Lee J, Leadon SA, Weinfeld M. Inducible repair of thymine glycol detected by an ultrasensitive assay for DNA damage. Science 280: 1066-1069 (1998).
27. Makinodan T, James SJ. T cell potentiation by low dose ionizing radiation: possible mechanisms. Health Phys 59(1):29-34 (1990).
28. Anderson RE. Effects of low-dose radiation on the immune response, Chapt. 5. In Biological Effects of Low Level Exposures: Dose-Response Relationships (Calabrese EJ, ed). Chelsea, MI: Lewis Publishers, 1992; 95-112.
29. Lithgow GJ, Kirkwood TBL. Mechanisms and evolution of aging. Science 273:80 (1996).
30. Wei Q, Matanoski GM, Farmer ER, Hedayati MA, Grossman L. DNA repair and aging in basal cell carcinoma: a molecular epidemiology study. Proc Natl Acad Sci USA 90:1614-1618 (1993).
31. Miller RA. The aging immune system: primer and prospectus. Science 273:70-74 (1996).
32. Ross DW. Biology of aging. Arch Pathol Lab Med 120:1148 (1996).
33. Duke RC, Ojcius DM, Young JD-E. Cell suicide in health and disease. Scientific American Dec: 80-87 (1996).
34. Mine M, Nakamura T, Mori H, Kondo H, Okajima S. The current mortality rates of A-bomb survivors in Nagasaki City. Jpn J Public Health 28: 337-342 (1981). (In Japanese with English abstract).
35. Azzam El, de Toledo SM, Raaphorst GP, Mitchel REJ. Low-dose ionizing radiation decreases the frequency of neoplastic transformation to a level below the spontaneous rate in C3H 10T1/2 cells. Radiat Res 146: 369-373(1996).
36. Melov S, Ravenscraft J, Malik S, et al. Extension of life-span with superoxide dismutase/catalase mimetics. Science 289: 1559(2000).
37. Makinodan, T., 1992, "Celllar and Subcellular Alteration in Immune Cells Induced by Chronic, Intermittent Exposure In Vivo to very Low Dose of Ionizing Radiation (LDR) and its Ameliorating Effects on Progression of Autoimmune Disease and Mammary Tumor Growth," In: Low-Dose Irradiation and Biological Defense Mechanisms. Ed.: Sugahara, T., Sagan, L.A., Aoyama, T., Exerpta Medica, Amsterdam, London, New York, Tokyo, 233-237.
38. Hashimoto, S., Shirato, H., Hosokawa, M., Nishioka, T., Kuramitsu, Y., Matushita, K., Kobayashi, M., and Miyasaka, K., 1999, "The Suppression of Metastases and the Change in Host Immune Response after Low-Dose Total-Body Irradiation in Tumor-Bearing Rats," Radiat Res 151:717-724.
39. Chaffey, J.T., Rosenthal, D.S., Moloney, W.D., and Hellman, S., 1976, "Total Body Irradiation as Treatment for Lymphosarcoma," Int. J. Radiat Oncol. Biol. Phys. 1:399-405.
40. Choi, N.C., Timothy, A.R. Kaufman, S.D., Carey, R.W., and Aisenbert, A.C., 1979, "Low Dose Fractionated Whole Body Irradiation in the Treatment of Advanced Non-Hodgkin’s Lymphoma," Cancer 43:1636-1642.
41. Sakamoto, K., Myogin, M., Hosoi, Y., Nemoto, K., Takai, Y., Kakuto, Y., Yamada, S., and Watabe, M., 1997, "Fundamental and Clinical Studies on Cancer Control with Total or Upper Half Body Irradiation," J Jpn Soc Ther Radiol Oncol 9:161-175.
42. Takai, Y., Yamada, S., Nemoto, K., Ogawa, Y., Kakuto, Y., Hosoi, Y., and Sakamoto, K., 1992, "Anti-Tumor Effect of Low Dose Total (or Half) Body Irradiation and Changes in the Functional Subset of Peripheral Blood Lymphocytes in Non-Hodgkin’s Lymphoma Patients after TBI (HBI)," In: Low-Dose Irradiation and Biological Defense Mechanisms (Sugahara, T., Sagan, L.A., and Aoyama, T., eds). Amsterdam, the Netherlands: Elsevier Science Publishers, 1992:113-116.
43. Anderson RE, Tokoda S, Williams WL, Spellman CW, Low dose irradiation permits immunization of A/J mice with subimmunogenic numbers of SaI cells. Brit. J. Cancer 54:505-510 (1986).